I am currently supporting my client to identify suitable individuals confident to move into a Leading PBPK role, providing the strategic influence within a team using modelling expertise. If you already have a strong experience with mechanistic PBPK and DDI models within drug development, and are keen to develop your level of accountability within an outstanding working environment, this will be a great role for you.
As PBPK Team Leader, you will be responsible for driving leading projects through discovery and development, with oversight to strategic planning of the innovative and quantitative approaches. You will be evaluating and implementing suitable approaches for translational modelling. You will also liaise with further technical scientists to generate data and support the build-up of the mechanistic models. Here, you will be looked on to build a strong external network within Modelling and Simulation, alongside further collaboration within academic partners and CROs. You will be responsible for a team, alongside PhD modellers, where will provide coaching and manage the group performance and operations.
The ideal candidate will have:
A PhD within a field related to PBPK modelling At least 7+ years industry experience Comprehensive knowledge of modelling software, such as SimCYP, GastroPlus, Phoenix, WinNonlin, Matlab etc, with a strong hands-on capability. Strong understanding of PPBK and DDI modelling with a strong ability to provide clear recommendations. Knowledge of the wider implications of DDI in regards to drug labelling Experience leading projects and teams, alongside problem-solving and solutions strategy experience is highly desirable. Significant publications record with focus on PBPK/DDI articles. Strong English spoken and written language skills
If you feel like this could be a great opportunity for your career, then please do get in touch. I am reachable on (0), or email a copy of your CV to . If this position does not quite hit the mark, then please get in touch to discuss your industry options.